Given the mechanistic link between ECD and GRP78 in inhibiting the PERK pathway to promote cell survival, it would be of great interest to explore if GRP78 and ECD are cooverexpressed in tumors that use the UPR to promote tumor cell survival and hence may be suitable targets for UPR-directed therapeutic agents. The gene discussed is ECD; the disease is neoplasm.